Advantage of the use of human liver S9 in the Ames test

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 438, Issue 1, 1999, Pages 29-36

  Hakura, Atsushi ^a   Suzuki, Satoshi ^b   Satoh, Tetsuo ^b  

^a EISAI CO LTD   (Japan)

^b Biomedical Research Institute   (Japan)

Author keywords

5,6 Benzoflavone; Ames test; Cytochrome P450; Human liver S9; Mutagenicity; Phenobarbital; Rat liver S9

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; 2 AMINO 3 METHYLIMIDAZO[4,5 F]QUINOLINE; 2 AMINOANTHRACENE; 6 CHRYSENAMINE; AFLATOXIN B1; AROMATIC AMINE; BENZO[A]PYRENE; BENZO[E]PYRENE; BETA NAPHTHOFLAVONE; CYTOCHROME P450; DIETHYLNITROSAMINE; DIMETHYLNITROSAMINE; N (2 FLUORENYL)ACETAMIDE; NITROPYRENE; NITROSAMINE; PHENOBARBITAL; POLYCYCLIC AROMATIC COMPOUND; S 9; UNCLASSIFIED DRUG; URETHAN;

AMES TEST; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME INDUCTION; HUMAN; HUMAN TISSUE; MALE; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SPECIES DIFFERENCE;

ANIMALS; BIOTRANSFORMATION; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; LIVER; MALE; MUTAGENICITY TESTS; MUTAGENS; RATS; RATS, SPRAGUE-DAWLEY; SALMONELLA TYPHIMURIUM;

EID: 0032902923     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(98)00159-4     Document Type: Article

References (28)

1. Maron D.M., Ames B.N. Revised methods for the Salmonella mutagenicity test. Mutat. Res. 113:1983;173-215.
2. Guengerich F.P., Shimada T. Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem. Res. Toxicol. 4:1991;391-407. and references cited therein.
3. Elliott B.M., Combes R.D., Elcombe C.R., Gatehouse D.G., Gibson G.G., Mackay J.M., Wolf R.C. Report of UK Environmental Mutagen Society Working Party: alternatives to Aroclor 1254-induced S-9 in in vitro genotoxicity assays. Mutagenesis. 7:1992;175-177.
4. Beaune P., Lemestré-Cornet R., Kremers P., Albert A., Gielen J. The Salmonella/mammalian microsome mutagenicity test: comparison of human and rat livers as activating systems. Mutat. Res. 156:1985;139-146.
5. Johnson T.E., Umbenhauer D.R., Galloway S.M. Human liver S-9 metabolic activation: proficiency in cytogenetic assays and comparison with phenobarbital/β-naphthoflavone or aroclor 1254 induced rat S-9. Environ. Mol. Mutagen. 28:1996;51-59.
6. Phillipson C.E., Ioannides C. Activation of aromatic amines to mutagens by various animal species including man. Mutat. Res. 124:1983;325-336.
7. Phillipson C.E., Ioannides C. A comparative study of the bioactivation of nitrosamines to mutagens by various animal species including man. Carcinogenesis. 5:1984;1091-1094.
8. Phillipson C.E., Ioannides C. Metabolic activation of polycyclic aromatic hydrocarbons to mutagens in the Ames test by various animal species including man. Mutat. Res. 211:1989;147-151.
9. Marczylo T., Ioannides C. Bioactivation of 6-aminochrysene by animal and human hepatic preparations: contributions of microsomal and cytosolic enzyme systems. Mutagenesis. 9:1994;233-239.
10. Le J., Jung R., Kramer M. Dedicated to Prof. Med. Helmut Kewitz in honour of his 65th birthday: effects of using liver fractions from different mammals, including man, on results of mutagenicity assays in Salmonella typhimurium. Fd. Chem. Toxicol. 23:1985;695-700.
11. Shimada T., Martin M.V., Pruess-Schwartz D., Marnett L.J., Guengerich F.P. Roles of individual human cytochrome P-450 enzymes in the bioactivation of benzo(a)pyrene, 7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene, and other dihydrodiol derivatives of polycyclic aromatic hydrocarbons. Cancer Res. 49:1989;6304-6312.
12. McManus M.E., Burgess W.M., Veronese M.E., Huggett A., Quattrochi L.C., Tukey R.H. Metabolism of 2-acetylaminofluorene and benzo(a)pyrene and activation of food-derived heterocyclic amine mutagens by human cytochromes P-450. Cancer Res. 50:1990;3367-3376.
13. Shimada T., Iwasaki M., Martin M.V., Guengerich F.P. Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens detected by umu gene response in Salmonella typhimurium TA1535/pSK1002. Cancer Res. 49:1989;3218-3228.
14. F.J. Gonzalez, T. Aoyama, H.V. Gelboin, Activation of promutagens by human cDNA-expressed cytochrome P450s, in: M.L. Mendelshon, R.J. Albertini (Eds.), Mutation and the Environment, Part B: Metabolism, Testing Methods, and Chromosomes, Wiley-Liss, New York, 1990, pp. 77-86.
15. Aoyama T., Gelboin H.V., Gonzalez F.J. Mutagenic activation of 2-amino-3-methylimidazo[4,5f]quinoline by complementary DNA-expressed human liver P-450. Cancer Res. 50:1990;2060-2063.
16. Crespi C.L., Penman B.W., Leakey J.A., Arlotto M.P., Stark A., Parkinson A., Turner T., Steimel D.T., Rudo K., Davies R.L., Langenbach R. Human cytochrome P450IIA3:cDNA sequence, role of enzyme in the metabolic activation of promutagens, comparison to nitrosamine activation by human cytochrome P450IIE1. Carcinogenesis. 11:1990;1293-1300.
17. Guengerich F.P., Kim D.-H., Iwasaki M. Role of human cytochrome P-450 IIE1 in the oxidation of several low molecular weight cancer suspects. Chem. Res. Toxicol. 4:1991;168-179.
18. Yoo J.S.H., Guengerich F.P., Yang C.S. Metabolism of N-nitrosodialkylamines by human liver microsomes. Cancer Res. 48:1988;1499-1504.
19. 6-ethenoadenosine. Chem. Res. Toxicol. 4:1991;413-421.
20. Brian W.R., Sari M.-A., Iwasaki M., Shimada T., Kaminsky L.S., Guengerich F.P. Catalytic activities of human liver cytochrome P-450 IIIA4 expressed in Saccharomyces cerevisiae. Biochemistry. 29:1990;11280-11292.
21. 1. Proc. Natl. Acad. Sci. USA. 87:1990;4790-4793.
22. 1 metabolism in human liver. Proc. Natl. Acad. Sci. USA. 87:1990;8306-8310.
23. Howard P.C., Aoyama T., Bauer S.L., Gelboin H.V., Gonzalez F.J. The metabolism of 1-nitropyrene by human cytochromes P450. Carcinogenesis. 11:1990;1539-1542.
24. 6-methylguanine DNA methyltransferases and highly sensitive to mutagenic alkylating agents. Mutat. Res. 381:1997;15-24.
25. Hakura A., Mochida H., Tsutsui Y., Yamatsu K. Mutagenicity and cytotoxicity of naphthoquinones for Ames Salmonella tester strains. Chem. Res. Toxicol. 7:1994;559-567.
26. NEWSLETTER, the Human and Animal Bridge Group, Vol. 3, 1997, pp. 7-8.
27. IARC, IARC Monographs on the evaluation of the carcinogenic risk of chemicals to man, Vol. 3, Certain polycyclic aromatic hydrocarbons and heterocyclic compounds, IARC, WHO, Lyon, France, 1973, pp. 91-136.
28. Hakura A., Tsutsui Y., Sonoda J., Kai J., Imade T., Shimada M., Sugihara Y., Mikami T. Comparison between in vivo mutagenicity and carcinogenicity in multiple organs by benzo[a]pyrene in the lacZ transgenic mouse (Muta™Mouse). Mutat. Res. 398:1998;123-130.